OpenAlex
PricingAboutJobs
Log inGet started
Work

Orexin Receptor Antagonists Differ from Standard Sleep Drugs by Promoting Sleep at Doses That Do Not Disrupt Cognition

HTML

Year: 2013
Type: article
Source: Science Translational Medicine
DOI: 10.1126/scitranslmed.3005213
Authors: Jason M. Uslaner, Spencer J. Tye, Donnie M. Eddins, Xiaohai Wang, Steven V. Fox, Alan T. Savitz, Jacquelyn Binns, Christopher E. Cannon, Susan L. Garson, Lihang Yao, Robert Hodgson, Joanne Stevens, Mark R. Bowlby, Pamela L. Tannenbaum, Joseph Brunner, Terrence P. Mcdonald, Anthony L. Gotter, Scott D. Kuduk, Paul J. Coleman, Christopher J. Winrow, John J. Renger
Institution: Merck & Co., Inc., Rahway, NJ, USA (United States)
Language: English

Topic: Sleep and Wakefulness Research
Subfield: Cognitive Neuroscience
Field: Neuroscience
Domain: Life Sciences
Keywords: orexin receptor antagonists, insomnia treatment, eszopiclone, zolpidem, diazepam, cognitive impairment, novel object recognition, Arc expression, hippocampal synaptic plasticity, sleep promotion
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2066700011
FWCI: 6.302
Cites: 71
Cited by: 97
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security